Close

Celgene (CELG) Price Target Raised to $134 at Deutsche Bank

October 24, 2014 9:07 AM EDT Send to a Friend
Deutsche Bank maintained a Buy rating on Celgene (NASDAQ: CELG) and raised its price target to $134.00 (from $115.00). Analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login